FRAXIPARINE 7600 IU AXa/0.8 ML
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
NADROPARIN CALCIUM 7600 IU / 0.8 ML
Available from:
GLAXO SMITH KLINE (ISRAEL) LTD
ATC code:
B01AB06
Pharmaceutical form:
SOLUTION FOR INJECTION
Administration route:
S.C
Manufactured by:
GLAXO WELLCOME PRODUCTION, FRANCE
Therapeutic group:
NADROPARIN
Therapeutic indications:
Prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. Treatment of constituted deep vein thrombosis. Prevention of coagulation in the extra corporeal circuit during haemodialysis. The prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.
Authorization date:
2010-07-01
